ORCHARD THERAPEUTICS NORTH AMERICA

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

7 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $1,840,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 2 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401108947), not by name.

Clients 1

ORCHARD THERAPEUTICS NORTH AMERICA $1,840,000 7 filings

Reported by year 2 years

2026 $660,000 2 filings
2025 $1,180,000 5 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

HOUSE OF REPRESENTATIVES 6
SENATE 6
Health & Human Services, Dept of (HHS) 4
Food & Drug Administration (FDA) 3
Centers For Medicare and Medicaid Services (CMS) 2

Recent filings 9 total

Q2

ORCHARD THERAPEUTICS NORTH AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $190,000 expenses · posted Jul 17, 2026

View → 1A

ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $470,000 expenses · posted Apr 29, 2026

View → Q1

ORCHARD THERAPEUTICS NORTH AMERICA Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $350,000 expenses · posted Apr 17, 2026

View → 2A

ORCHARD THERAPEUTICS NORTH AMERICA

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $430,000 expenses · posted Mar 13, 2026

View → Q4

ORCHARD THERAPEUTICS NORTH AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $260,000 expenses · posted Jan 20, 2026

View → Q3

ORCHARD THERAPEUTICS NORTH AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $220,000 expenses · posted Oct 16, 2025

View → RA

ORCHARD THERAPEUTICS NORTH AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 16, 2025

View → Q2

ORCHARD THERAPEUTICS NORTH AMERICA Amended

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $220,000 expenses · posted Jul 17, 2025

View → Q1

ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $270,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.